[Drug interactions in the use of steroid hormones, especially oral contraceptives].
D001711:Biotransformation; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects* / Q000378:metabolism; D019363:Cytochrome P-450 CYP1A1; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006900:Hydroxylation; D008099:Liver / Q000187:drug effects; D008657:Metabolic Clearance Rate / Q000187:drug effects; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects; D013250:Steroid Hydroxylases / Q000037:antagonists & inhibitors
D003278:Contraceptives, Oral, Hormonal; D010672:Phenytoin; D013250:Steroid Hydroxylases; D019363:Cytochrome P-450 CYP1A1; C020120:estrogen 2-hydroxylase; D012293:Rifampin; D010634:Phenobarbital
Arzneimittelinteraktionen bei der Anwendung von Steroidhormonen, insbesondere von oralen Kontrazeptiva.